These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17392247)

  • 1. Imaging prostate cancer: a multidisciplinary perspective.
    Hricak H; Choyke PL; Eberhardt SC; Leibel SA; Scardino PT
    Radiology; 2007 Apr; 243(1):28-53. PubMed ID: 17392247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer imaging: what the urologist wants to know.
    Talab SS; Preston MA; Elmi A; Tabatabaei S
    Radiol Clin North Am; 2012 Nov; 50(6):1015-41. PubMed ID: 23122036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer imaging.
    Fuchsjäger M; Shukla-Dave A; Akin O; Barentsz J; Hricak H
    Acta Radiol; 2008 Feb; 49(1):107-20. PubMed ID: 18210320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level.
    Hricak H; Schöder H; Pucar D; Lis E; Eberhardt SC; Onyebuchi CN; Scher HI
    Semin Oncol; 2003 Oct; 30(5):616-34. PubMed ID: 14571410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging prostate cancer.
    Jung AJ; Westphalen AC
    Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear medicine studies of the prostate, testes, and bladder.
    Jana S; Blaufox MD
    Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT and radiotherapy in prostate cancer.
    De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of prostate cancer.
    Akin O; Hricak H
    Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy.
    Vilanova JC; Comet J; Barceló-Vidal C; Barceló J; López-Bonet E; Maroto A; Arzoz M; Moreno A; Areal J
    Radiology; 2009 Oct; 253(1):135-43. PubMed ID: 19703854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging prostate cancer.
    Yu KK; Hricak H
    Radiol Clin North Am; 2000 Jan; 38(1):59-85, viii. PubMed ID: 10664667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in prostate cancer staging: present role and future perspectives.
    Pinto F; Totaro A; Palermo G; Calarco A; Sacco E; D'Addessi A; Racioppi M; Valentini A; Gui B; Bassi P
    Urol Int; 2012; 88(2):125-36. PubMed ID: 22286304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
    Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C
    Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
    John SS; Zietman AL; Shipley WU; Harisinghani MG
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S43-7. PubMed ID: 18406936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging and MR spectroscopic imaging of prostate cancer.
    Rajesh A; Coakley FV
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.
    Seltzer MA; Barbaric Z; Belldegrun A; Naitoh J; Dorey F; Phelps ME; Gambhir SS; Hoh CK
    J Urol; 1999 Oct; 162(4):1322-8. PubMed ID: 10492189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects in radionuclide imaging of prostate cancer.
    Lütje S; Boerman OC; van Rij CM; Sedelaar M; Helfrich W; Oyen WJ; Mulders PF
    Prostate; 2012 Aug; 72(11):1262-72. PubMed ID: 22127918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging of cancer prostate].
    Ghouadni M; Sandoz C; Eiss D; Cornud F; Thiounn N; Hélénon O
    Rev Prat; 2003 Dec; 53(20):2237-43. PubMed ID: 15018077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.